Fluoride dental floss
Executive Summary
FDA should amend OTC Anticaries Drug Products TFM to disallow "the OTC marketing of sodium fluoride treated dental floss in the absence of clinical data showing superiority over comparable floss" without the cavity-fighting ingredient, Squibb unit Princeton Pharmaceuticals argues in a Nov. 14 petition. Firm maintains GRAS/E status of fluoride cannot be extended to a medical device (floss) on bioequivalency grounds as proposed by Johnson & Johnson in a July 1986 petition. J&J argued that dental floss can deliver fluoride with efficacy comparable to other methods of application ....
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.